NFL Biosciences Secures €500K Funding for Novel Nicotine Addiction Treatment
Montpellier, France – NFL Biosciences, a biopharmaceutical company specializing in botanical drugs for addiction treatment, has received a significant financial boost. Bpifrance has granted the company a €500,000 loan to support the preparation of its Phase 2 clinical trial application for NFL-102, a novel drug candidate targeting nicotine addiction. The loan, announced on March 11, … Read more